Veeda Clinical Research   Report issue

For profit Phase 1 Phase 2 Phase 4
Founded: Ahmedabad India (2004)

Organization Overview

First Clinical Trial
2004
NCT01062867
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Veeda Clinical Research, India | Veeda Clinical Research (P) Ltd | Veeda Clinical research private limited | veeda clinical research Pvt. Ltd | Veeda Clinical Research Pvt. Ltd | Veeda Clinical Research Pvt. Ltd. | Veeda Clinical Research Pvt. Ltd., | Veeda clinical research Pvt. Ltd., India | Veeda Oncology

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 2)

Cachexia (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Colorectal Neoplasms (Phase 2)

Diabetes Mellitus, Type 2 (Phase 1)

Lung Neoplasms (Phase 2)

Malnutrition (Phase 1)

Myelodysplastic Syndromes (Phase 2)

Nausea (Phase 4)

Nocturia (Phase 2)

Preleukemia (Phase 2)

Prostatic Neoplasms (Phase 2)

Syndrome (Phase 2)

Toothache (Phase 1)

Vomiting (Phase 4)

Wasting Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 35
  • # of Trial APIs: 28